BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251201
DTEND;VALUE=DATE:20251204
DTSTAMP:20260515T025603
CREATED:20250812T105107Z
LAST-MODIFIED:20250812T105107Z
UID:41720-1764547200-1764806399@www.pharmajournalist.com
SUMMARY:9th Complement-Based Drug Development Summit
DESCRIPTION:Diving Into the Complement Cascade to Explore Intervention Points\, Harnessing Biomarker Strategies to Identify Optimal Patient Populations\, & Exploring the Therapeutic Opportunity from Rare Disease to Inflammation to Autoimmune Disease. \nSo far\, 2025 has brought significant excitement and progress to the complement-based therapeutic landscape. Leading biopharma companies like Novartis\, Annexon Biosciences and Omeros\, are making significant clinical progress in PNH\, AMD\, IgAN and C3G\, whilst key academics such as Michael Holers\, Michael Brenner\, and Brahm Segal continue to make discoveries in complement imaging\, novel pathways\, and new therapeutics areas such as oncology and transplantation. \nThe Complement-Based Drug Development Summit returns for its 9th year to unite the leading experts in complement biology and therapeutic development\, from innovative biotech to impactful large pharma and academic experts. This meeting will harness the energy and dedication deepening the current understanding of the complement system to advance drug development in rare disease and beyond with patients at the forefront. \nJoin us at the 2025 meeting to gain insights from 20+ expert speakers covering the end-to-end complement-based drug development\, from basic biology to diagnostics and clinical development. \nParticipate in three dedicated workshops for active discussion on key topics including the intracellular complement system\, bispecific complement mediators\, and innovative delivery of complement-based therapeutics to ensure delivery to the correct targets. \nThis comprehensive program spans a broad spectrum of renal\, ophthalmic\, neurological\, and haematological indications\, mirroring the shift in focus of the complement field from rare orphan indications to larger patient populations. \nJoin 80+ industry experts this December and access exclusive insights into therapeutic development across the complement field and bring actionable learnings and competitive intelligence back to your team.
URL:http://www.pharmajournalist.com/event/9th-complement-based-drug-development-summit/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251201
DTEND;VALUE=DATE:20251204
DTSTAMP:20260515T025603
CREATED:20250820T123645Z
LAST-MODIFIED:20250820T123645Z
UID:41743-1764547200-1764806399@www.pharmajournalist.com
SUMMARY:7th Cell Therapy Analytical Development Summit
DESCRIPTION:Recognized as the industry’s leading forum for cell therapy analytical\, quality control\, assay\, and CMC professionals\, the 7th Cell Therapy Analytical Development Summit\, returns to Boston to provide the expertise needed to prepare your teams for clinical and commercial readiness. Hear directly 80+ experts from Takeda\, Arsenal Bio\, Bayer\, Genentech\, Adicet Bio\, Quell Therapeutics\, and the National Institute of Health\, as they share proven strategies\, innovative technologies and best-in-class approaches to enhance your product safety and quality\, ahead of regulatory approval. \nNow combined with the previously separate\, Cell Therapy Potency Assay Summit\, this meeting provides you with an even more comprehensive agenda\, covering the full landscape of analytical development\, across early- and late-stage assay development tracks. Join us this December to fast-track the next era of safe\, potent and robust cell therapies to market! \nFor more information\, please visit https://ter.li/9uagdj
URL:http://www.pharmajournalist.com/event/7th-cell-therapy-analytical-development-summit/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR